Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status updated to no longer look for participants. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment header was reformatted, and the page revision version updated to v3.6.0.SummaryDifference0.5%

- Check19 days agoChange DetectedThe page now shows revision v3.5.5, replacing v3.5.4, indicating a minor update to the page version. No substantive study details appear to have changed.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study sponsor is updated from Galapagos NV to Lakefront Biotherapeutics NV, reflecting a change in the organization responsible for the trial.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor version update to the study details page. This reflects an administrative update and does not modify the study content or data visible to users.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a newer version of the page. This likely reflects minor edits or maintenance to the study record presentation.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no user-facing content changes.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.